Quick Search

 

 


 

 

Result Summary for 101468/163

Result Summary
Protocol ID: 101468/163
Clinical Study ID: 101468/163
Official Title: A double-blind, two-way cross-over, placebo-controlled single dose and repeat dose study to investigate the pharmacokinetics of ropinirole after single and multiple doses of a CR-formulation in healthy male and female subjects.
Phase: Phase 1
Study Indications or Diseases:
  • Parkinson Disease
Generic Name: ropinirole
Trade/Product Name: requip;requip
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.